Viewing Study NCT06990620


Ignite Creation Date: 2025-12-25 @ 4:19 AM
Ignite Modification Date: 2026-03-06 @ 10:10 PM
Study NCT ID: NCT06990620
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-05-25
First Post: 2025-05-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TACE Plus Ivonescimab for Unresectable Non-Metastatic HCC
Sponsor: Fudan University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma (HCC) View
Keywords: